🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementPancreatitis risk assessment — pooled safety analysis

Pancreatitis risk assessment — pooled safety analysis

Dr.MetabolicMD Thu, Mar 12, 2026 at 2:11 AM 15 replies 291 viewsPage 1 of 3
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Mar 12, 2026 at 3:36 AM#1

My friend sent me an article about GLP-1 drugs and pancreatitis and now I'm spiraling. I've been on tirzepatide for 3 months and I'm losing weight beautifully but now every stomach pain has me convinced my pancreas is dying.

How real is this risk? What should I actually watch for? I need someone to either calm me down or tell me to stop the medication because the anxiety is eating me alive.

20 3SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 17 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Mar 12, 2026 at 3:53 AM#2

Let me give you the data so you can calibrate your worry appropriately.

The short answer: the risk is real but very small, and the data is more nuanced than scary headlines suggest.

Here's what we know:

  • In the STEP and SURMOUNT trials, acute pancreatitis occurred in <0.2% of participants on active drug vs. ~0.1% on placebo
  • The absolute risk increase is approximately 1 extra case per 1000 patients
  • The SUSTAIN and PIONEER programs (semaglutide for diabetes, larger datasets) showed similar low rates
  • The large cardiovascular outcomes trial SELECT (17,604 participants) did NOT show a statistically significant increase in pancreatitis with semaglutide

For context:

The background rate of acute pancreatitis in the obese population is already 2-3x higher than the general population, independent of any medication. Obesity itself is a risk factor for pancreatitis.

So while we do counsel patients about the risk and monitor for symptoms, this is NOT a reason to panic or stop a medication that's providing significant metabolic benefit.

Last edited: Mar 12, 2026 at 9:53 AM
22 24InsuranceTom, WendyG_ATL, SaraMom3 and 19 others
Reply Quote Save Share Report
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
Mar 12, 2026 at 4:10 AM#3

Adding some numbers for the data-driven folks:

TrialDrugPancreatitis (Drug)Pancreatitis (Placebo)
STEP 1Semaglutide 2.4mg0.1%0%
SURMOUNT-1Tirzepatide (all doses)0.1%0.1%
SELECTSemaglutide 2.4mg0.2%0.2%
SURPASS-4Tirzepatide (all doses)0.1%N/A (active comparator)

The numbers are tiny and often not statistically different from placebo. Compare this to the risk of pancreatitis from alcohol use (~5-10/1000/year in heavy drinkers) or gallstones (~2-5/1000/year). GLP-1 RAs are quite low on the pancreatitis risk hierarchy.

2 4MikeNYC_runner
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.NutriCornell
Senior Member
1,345
6,234
Mar 2024
Ithaca, NY
Mar 12, 2026 at 4:27 AM#4

I went through this exact anxiety spiral at month 2. Every gas pain, every stomach gurgle, I was convinced it was pancreatitis. My doctor told me something that really helped:

"If you have pancreatitis, you will not be confused about whether you have pancreatitis."

Acute pancreatitis causes severe, unrelenting epigastric pain that radiates to the back, often with vomiting, and it doesn't come and go — it stays and gets worse. It sends people to the ER. The vague GI discomfort we all get on GLP-1s is not pancreatitis.

That said, know the warning signs and take them seriously if they occur. But don't torture yourself with anxiety over a <0.2% risk while missing out on the proven benefits of the medication.

Last edited: Mar 12, 2026 at 6:27 AM
6 18JenMemphis, pat_auckland, Dr.GastroMayo and 3 others
Reply Quote Save Share Report
AmyNC_wife
Member
634
2,890
Jun 2024
North Carolina
Mar 12, 2026 at 4:44 AM#5

Something my GI doc told me: if you have a history of pancreatitis or a strong family history of pancreatic disease, GLP-1 RAs may not be appropriate for you and that's a conversation worth having. For the rest of us with no history, the risk doesn't warrant the anxiety.

Also worth noting: heavy alcohol use + GLP-1 RA is probably a bad combination if we're talking about pancreatitis risk. If you're a regular drinker, that's a much bigger risk factor than the drug itself.

12 4Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 9 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Fatigue on semaglutide — caloric deficit vs direct drug effect25 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register